US 11166963
Natural combination hormone replacement formulations and therapies
granted A61KA61K31/565A61K31/57
Quick answer
US patent 11166963 (Natural combination hormone replacement formulations and therapies) held by Compass Therapeutics LLC expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Compass Therapeutics LLC
- Grant date
- Tue Nov 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/565, A61K31/57, A61K47/10, A61K47/14